![]() |
市場調查報告書
商品編碼
1324308
2030 年脈搏血氧儀市場預測:按產品、類型、年齡層、技術、最終用戶和地區進行的全球分析Pulse Oximeter Market Forecasts to 2030 - Global Analysis By Product (Sensors, Equipment and Other Products), Type, Age Group, Technology, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球脈搏血氧計市場規模為 26 億美元,預計在預測期內將以 11.4% 的年複合成長率成長,到 2030 年達到 55 億美元。
一種稱為脈搏血氧計的醫療設備檢測患者血液中的氧氣含量。這是一種類似夾子的小型設備,可外部連接到人的手指、腳趾或耳垂上,以檢測氧氣的消耗時間和消耗量。在醫院病房,人們在手術、危機、治療和康復期間定期檢查脈搏。檢測將光發射到接觸點,並檢測有多少光可以流向另一端,從而計算出紅細胞中的氧氣量。
根據國際糖尿病聯盟的數據,到 2021 年,大約有 5.37 億成年人將患有糖尿病。預計到 2045 年,糖尿病患者總數將增至 6.43 億。
醫療設備脈搏血氧計市場的參與者可能會經歷新興經濟體推動的巨大發展潛力。中國和印度等國家的政府不斷增加在基於價值的護理和醫療保健現代化方面的支出。此外,醫療器械和學名藥製造地正在新興國家興起。
專注於健康技術的公司目前正在挑戰傳統市場。市場上現在有配備追蹤血液中 SpO2 水平的感測器的智慧手錶,以及心率和脈搏率監測以及日常能耗等其他功能。因此,脈搏血氧計市場的發展可能會因未來幾年替代血氧測定設備的出現而受到阻礙。
全世界最常見的呼吸系統疾病是肺炎、氣喘和慢性阻塞性肺病(COPD)。慢性阻塞性肺病、氣喘和肺炎等疾病會堵塞肺部氣道,導致呼吸困難,最終降低血氧水平。因慢性阻塞性肺病、氣喘或肺炎而出現缺氧的患者需要氧氣療法。脈搏血氧儀是一種無創測試,檢測嚴重不適且呼吸困難的患者的氧飽和度。檢測到並顯示在脈搏血氧計螢幕上的量對應於紅細胞的氧合。
“OTC”醫療產品是指已獲得適當醫療機構批准、無需處方即可直接銷售給消費者的產品。 OTC 脈搏血氧計不需要 FDA 批准,無需處方即可在任何藥房購買。然而,市售脈搏血氧計的可靠性和安全性值得懷疑。
在分析期間,由於COVID-19的影響,市場預計將大幅成長。這是由於親自前往醫療機構的次數減少以及指尖脈搏血氧計的部署顯著增加,這兩者都得到了有利法規的支持。患者氧飽和度低是由於COVID-19重症病例增加,增加了對危重患者持續護理的需求。根據 2021 年《印度斯坦時報》發表的一項研究,印度 AIIMS Jhajjar 收治的 COVID-19 患者中,約有 40% 入院時的氧飽和度水平低於 94%。由於 COVID-19 患者的血氧飽和度水平下降以及政府加大對使用這些產品持續監測血氧水平的支持,市場規模顯著擴大。
拋棄式感測器領域在預測期內佔據了最大的市場佔有率,因為它具有非侵入性監測潛力和輕量級特性,可以提高患者滿意度。此外,拋棄式感測器由於其所用軟質材料具有良好的彈性和生物相容性,因此適合長期監測。由於拋棄式感測器血氧計預防 HAI 和交叉污染的能力得到提高,其使用正在進一步加速。霍尼韋爾國際公司是拋棄式感測器的先驅。
由於慢性呼吸道疾病(包括慢性阻塞性肺病和氣喘)在成年人中的患病率不斷上升,以及需要持續病患監測的成人住院人數不斷增加,預計成人市場在預測期內將實現盈利成長。預計這一目標將會實現。此外,由於老年人口的顯著增加,對脈搏血氧計的需求也在增加,因為監測SpO2等生命指標對於老年人來說至關重要。
由於新產品和法規批准的增加,北美佔據了大部分市場佔有率。該地區呼吸系統疾病患病率的上升以及最先進的醫療基礎設施也支持了成長。此外,無線脈搏血氧儀的快速採用和家庭醫療保健中血氧儀的使用不斷增加,以及由於技術先進的醫療保健系統和高疾病負擔而導致的住院人數增加,推動了該地區的市場。
由於慢性病患病率較高,預計亞太地區的成長率最高。此外,人口眾多、收入水平不斷提高以及患者對最先進脈搏血氧計的認知不斷提高,將有助於市場的進一步擴張。此外,推動該地區擴張的要素包括目標疾病的高頻率、醫療保健基礎設施的進步以及公眾對有效病患監測技術的了解的增加。
According to Stratistics MRC, the Global Pulse Oximeter Market is accounted for $2.6 billion in 2023 and is expected to reach $5.5 billion by 2030 growing at a CAGR of 11.4% during the forecast period. A piece of medical equipment called a pulse oximeter examines the level of oxygen in a patient's blood. It is a tiny clip-like instrument that, when externally linked to a person's finger, toe, or earlobe, measures when and how much oxygen is being used up. People's pulses are regularly checked in hospital wards during procedures, crises, treatments, and recovery. The instrument sends light through the point of contact and measures how much can flow to the other end in order to calculate the amount of oxygen in red blood cells.
According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes. Total number of people living with diabetes is projected to rise to 643 million by 2045.
Players in the pulse oximeter market for medical devices are likely experiencing tremendous development potential due to emerging economies. Governments in countries like China and India are consistently increasing their expenditures on value-based care and healthcare modernization. Additionally, manufacturing hubs for medical equipment and generic medications are emerging in emerging nations.
Companies that are placing a greater emphasis on health technology are currently challenging the traditional market. Smartwatches with sensors that track SpO2 levels in the blood are now available on the market, along with other capabilities like heart rate and pulse rate monitoring and routine energy consumption. The development of the pulse oximeter market will therefore be hampered in the coming years by the availability of substitute oximetry devices.
Among the most common respiratory illnesses worldwide are pneumonia, asthma, and chronic obstructive pulmonary disease (COPD). The lungs' airways get clogged in conditions including COPD, asthma, and pneumonia, making it challenging to breathe in and out and finally resulting in low blood oxygen levels. Patients who experience hypoxia as a result of COPD, asthma, or pneumonia require oxygen therapy. The noninvasive test of pulse oximetry measures oxygen saturation in individuals who are critically unwell and have trouble inhaling. The amount detected and displayed on the pulse oximeter's screen corresponds to the oxygenation of red blood cells.
"OTC" medical items are those that have been approved by the appropriate medical authorities for direct sale to consumers without a prescription. OTC pulse oximeters do not require FDA approval and can be purchased without a prescription from any pharmacy. However, there are issues with the reliability and safety of over-the-counter pulse oximeters.
During the analysis period, it is anticipated that COVID-19's impact will cause the market to grow by significant amounts. This is due to a drop in in-person visits to healthcare facilities and a considerable rise in the deployment of fingertip pulse oximeters, both of which are supported by favorable regulations. Low oxygen saturation levels in the patients were caused by the rise of severe COVID-19 cases, which increased the demand for ongoing care of critically ill patients. According to a study that appeared in the Hindustan Times in 2021, approximately 40% of COVID-19 patients hospitalized at AIIMS Jhajjar in India had oxygen saturation levels below 94% when they were admitted. The market size significantly increased as a result of COVID-19 patients' declining oxygen saturation levels and growing government support for using these products to continuously monitor oxygen levels.
the disposable sensor segment held the largest market share during the anticipated period, due to its potential for non-invasive monitoring and its lightweight nature for greater patient satisfaction. Furthermore, disposable sensors are outstanding and well-suited for long-term monitoring due to their great flexibility and the biocompatibility of the soft material used. Disposable sensor oximeters' improved capacity to stop HAIs and cross-contamination has further accelerated their use. Among the pioneers in the provision of disposable sensors is Honeywell International Inc.
Owing to the increased prevalence of chronic respiratory diseases, including COPD and asthma, in the adult population as well as the rising number of adult hospitalizations necessitating ongoing patient monitoring, the adult segment is predicted to experience profitable growth over the course of the projected period. Additionally, the large increase in the elderly population has increased demand for pulse oximeters because monitoring vital indicators like SpO2 is essential for the elderly population.
Due to an increase in new products and regulatory approvals, North America held the majority of the market share. Additionally, the region's growth is being fueled by the rising prevalence of respiratory disorders and the presence of cutting-edge healthcare infrastructure in the area. Moreover, the market in the region is expected to be driven by the rapid adoption of wireless pulse oximeters and the growing use of oximeters in home healthcare and also by presence of a technologically proficient healthcare system and an increase in hospital admissions because of the high disease burden.
Owing to the high prevalence of chronic diseases there, the Asia-Pacific area is anticipated to develop at the highest rate. Furthermore, a large population, increased income levels, and increased patient awareness of cutting-edge pulse oximeters would all contribute to further market expansion. Additionally, factors promoting regional expansion include the high frequency of target diseases, advancements in healthcare infrastructure, and growing public knowledge of effective patient monitoring technologies.
Some of the key players in Pulse Oximeter market include: GE Healthcare , Dragerwerk AG & Co. KGaA, General Electric, ICU Medical, Inc., Koninklijke Philips N.V., Masimo, Medtronic, NIHON KOHDEN CORPORATION, Nonin and OSI Systems, Inc.
In June 2022, the Garmin Vivosmart 5 fitness band was introduced in India. The new fitness tracker features blood oxygen level monitoring, step counting, calorie counting, stress tracking, heart rate monitoring, body battery energy monitoring, and women's health tracking.
In December 2021, Telli Health announced the delivery of its first U.S. FDA certified and approved 4G cellular-connected SpO2 oximeter. This oximeter and its remote patient monitoring devices help track the COVID-19 patients during the pandemic.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.